Equity Overview
Price & Market Data
Price: $0.0085
Daily Change: $0.00 / 0.00%
Daily Range: $0.007 - $0.0088
Market Cap: $3,917,677
Daily Volume: 327,000
Performance Metrics
1 Week: 16.44%
1 Month: 4.94%
3 Months: -7.61%
6 Months: -39.54%
1 Year: 22.83%
YTD: -2.86%
Details
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a disease-modifying anti-rheumatic drug, for the treatment of infectious diseases, including influenza and COVID-19, as well as to treat pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. The company also develops Psilocybin, which is in Phase 1 clinical study for treating methamphetamine use disorder; and Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases. Revive Therapeutics Ltd. is based in Toronto, Canada.